An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samplesBenjamin Schoeps, Krishna Das, Can Yurttas et al.|Oncogene|2026Cited by 0
Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell responseSabrina Schneider, Tobias Nolden, Theresa Schwaiger et al.|Molecular Therapy Oncology|2026Cited by 0